Emerging Infectious Diseases (Oct 2017)

Fatal Rocky Mountain Spotted Fever along the United States–Mexico Border, 2013–2016

  • Naomi A. Drexler,
  • Hayley Yaglom,
  • Mariana Casal,
  • Maria Fierro,
  • Paula Kriner,
  • Brian Murphy,
  • Anne Kjemtrup,
  • Christopher D. Paddock

DOI
https://doi.org/10.3201/eid2310.170309
Journal volume & issue
Vol. 23, no. 10
pp. 1621 – 1626

Abstract

Read online

Rocky Mountain spotted fever (RMSF) is an emerging public health concern near the US–Mexico border, where it has resulted in thousands of cases and hundreds of deaths in the past decade. We identified 4 patients who had acquired RMSF in northern Mexico and subsequently died at US healthcare facilities. Two patients sought care in Mexico before being admitted to US-based hospitals. All patients initially had several nonspecific signs and symptoms, including fever, headache, nausea, vomiting, or myalgia, but deteriorated rapidly without receipt of a tetracycline-class antimicrobial drug. Each patient experienced respiratory failure late in illness. Although transborder cases are not common, early recognition and prompt initiation of appropriate treatment are vital for averting severe illness and death. Clinicians on both sides of the US–Mexico border should consider a diagnosis of RMSF for patients with rapidly progressing febrile illness and recent exposure in northern Mexico.

Keywords